Relationship between pretreatment viremia level and response to interferon-α therapy in chronic hepatitis c differs in viral type 1 and 2 infections
Authors:
- 1 October 1996
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 41 (10) , 1925-1932
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Variability of hepatitis C virusHepatology, 1995
- The HCV-bDNA probe method for measurement of HCV-RNA counts by HCV genotypeInternational Hepatology Communications, 1994
- Viral and host factors that contribute to efficacy of interferon-α2a therapy in patients with chronic hepatitis CDigestive Diseases and Sciences, 1994
- Randomized controlled trial of recombinant alpha-2a-interferon for chronic hepatitis CDigestive Diseases and Sciences, 1993
- Quantitative analysis of hepatitis C virus RNA by competitive nested polymerase chain reactionJournal of Gastroenterology and Hepatology, 1993
- Clinical backgrounds of the patients having different types of hepatitis C virus genomesJournal of Hepatology, 1992
- Randomized, double-blind, placebo-controlled trial of eight-week course of recombinant ?-interferon for chronic non-A, non-B hepatitisDigestive Diseases and Sciences, 1991
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†Hepatology, 1981